Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, MEISTER PAUL M, holds the title of Director at Amneal Pharmaceuticals, Inc..
On 2026-05-07, the insider transacted 48,747 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
MEISTER PAUL M (Director) exercised options for $0 of $AMRX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.